These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 32167395)
21. [Pharmacovigilance of parenterally administered salvianolate based on analysis of spontaneous reporting system data]. Lu PF; Xiang YY; Xie YM; Chang YP; Wang ZG Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3003-7. PubMed ID: 24471320 [TBL] [Abstract][Full Text] [Related]
22. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands. Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243 [TBL] [Abstract][Full Text] [Related]
23. Patterns of adverse drug reaction signals in NAFDAC Pharmacovigilance activities from September to November, 2014. Awodele O; Ibrahim A; Orhii P Int J Risk Saf Med; 2016 Mar; 28(1):13-23. PubMed ID: 27176753 [TBL] [Abstract][Full Text] [Related]
24. Paradoxical adverse drug reactions: descriptive analysis of French reports. Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024 [TBL] [Abstract][Full Text] [Related]
25. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics. Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073 [TBL] [Abstract][Full Text] [Related]
26. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Cliff-Eribo KO; Sammons H; Choonara I Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085 [TBL] [Abstract][Full Text] [Related]
27. Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority. Ribeiro-Vaz I; Marques J; Demoly P; Polónia J; Gomes ER Eur J Clin Pharmacol; 2013 Mar; 69(3):673-81. PubMed ID: 22915040 [TBL] [Abstract][Full Text] [Related]
28. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre. Shalviri G; Yousefian S; Gholami K J Clin Pharm Ther; 2012 Aug; 37(4):448-51. PubMed ID: 22122488 [TBL] [Abstract][Full Text] [Related]
29. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance. Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717 [TBL] [Abstract][Full Text] [Related]
30. Adverse reactions to contrast media: an analysis of spontaneous reports in the database of the pharmacovigilance programme of India. Kalaiselvan V; Sharma S; Singh GN Drug Saf; 2014 Sep; 37(9):703-10. PubMed ID: 25085041 [TBL] [Abstract][Full Text] [Related]
31. Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®. Pokladnikova J; Meyboom RH; Meincke R; Niedrig D; Russmann S Drug Saf; 2016 May; 39(5):455-64. PubMed ID: 26936182 [TBL] [Abstract][Full Text] [Related]
32. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented. Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001 [TBL] [Abstract][Full Text] [Related]
33. [Knowledge creation about adverse drug reactions in the paediatric population]. Aagaard L Ugeskr Laeger; 2013 Feb; 175(6):342-5. PubMed ID: 23402239 [TBL] [Abstract][Full Text] [Related]
34. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database. Castillon G; Salvo F; Moride Y Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742 [TBL] [Abstract][Full Text] [Related]
35. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Jose J; Rao PG Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163 [TBL] [Abstract][Full Text] [Related]
36. Inhaled Drug Therapy-Associated Adverse Reactions in Obstructive Respiratory Diseases: A Review of a Decade of Reporting to the Portuguese Pharmacovigilance System. Fonseca W; Monteiro C; Taborda-Barata L Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886135 [TBL] [Abstract][Full Text] [Related]
37. Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) database. Suwankesawong W; Saokaew S; Permsuwan U; Chaiyakunapruk N BMC Complement Altern Med; 2014 Dec; 14():515. PubMed ID: 25539642 [TBL] [Abstract][Full Text] [Related]
38. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden. Holm L; Ekman E; Jorsäter Blomgren K Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):335-343. PubMed ID: 28071845 [TBL] [Abstract][Full Text] [Related]
39. Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System. Martins AS; Monteiro C; Duarte AP Pharmacol Res Perspect; 2024 Oct; 12(5):e1235. PubMed ID: 39291726 [TBL] [Abstract][Full Text] [Related]
40. Biological therapy-associated adverse reactions in asthma: analysis of reporting to the Portuguese pharmacovigilance system. Sousa J; Taborda-Barata L; Monteiro C Expert Opin Drug Saf; 2020 Jan; 19(1):99-106. PubMed ID: 31661986 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]